低收入和中等收入国家城乡结核病患病率:系统综述与荟萃分析
该系统综述与荟萃分析纳入47项调查、2454443名参与者,评估中低收入国家成人肺结核患病率的城乡差异。细菌学确诊结核的城乡患病率比为1.09(95%CrI:0.90,1.30),涂片阳性结核为1.24(95%CrI:0.94,1.61);2000至2024年间城乡患病率比呈上升趋势,年均增加2.4%(95%CrI:-0.8%,6.0%)。
要点
- 中低收入国家城乡结核患病率总体差异不大,但WHO区域间存在实质性差异。
- 2000至2024年结核疫情日益城市化,城市病例占比在几乎所有国家上升。
- 需针对城乡结核流行病学和人口学特征制定差异化公共卫生策略。
核心结论
- 2000至2024年间,结核疫情在比例和绝对数上均日益城市化,但各国各区域时间变化差异显著。
研究设计与样本
- 纳入47项2000至2024年调查,共2454443名参与者,排除仅针对有症状或就医者及聚集场所研究。
- 采用贝叶斯多层荟萃回归估计城乡患病率比,并拟合贝叶斯多变量模型估算城乡患病人数。
主要发现
- 细菌学确诊结核的合并城乡患病率比为1.09(95%CrI:0.90,1.30),涂片阳性结核为1.24(95%CrI:0.94,1.61)。
- 非洲区域城市细菌学确诊患病率较高(PR 1.18,95%CrI:0.91,1.52),西太平洋区域(PR 0.85,95%CrI:0.64,1.07)和东南亚区域(PR 0.86,95%CrI:0.67,1.08)城乡大致相似。
- 2000至2024年细菌学确诊结核城乡患病率比年均增加2.4%(95%CrI:-0.8%,6.0%)。
临床怎么用
- 应认识结核负担日益城市化,在城市和农村地区采取与各自流行病学和人口学特征相匹配的公共卫生干预。
局限性
- 城乡定义缺乏统一标准。
- 部分全球区域(如美洲和欧洲)缺乏数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urban and rural settings differ in key determinants of tuberculosis (TB) burden, including transmission dynamics, social and structural determinants, and healthcare access. However, understanding of urban and rural TB burden is limited, hindering implementation of public health interventions to end TB. METHODS AND FINDINGS: We conducted a systematic review and meta-analysis of urban and rural differences in adult pulmonary TB prevalence in low- and middle-income countries. We searched PubMed, Embase, Global Health, the Cochrane Library, Africa Index Medicus, LILACS, and SciELO for community-representative prevalence surveys conducted between 1st January 1993 and 14th October 2025. Studies focussing solely on symptomatic or healthcare-seeking individuals and those conducted in congregate settings like prisons, universities, and health facilities were excluded. Risk of bias was assessed using a tool for prevalence surveys. Bayesian multilevel meta-regression was used to estimate pooled urban-to-rural prevalence ratios (PR) for bacteriologically-confirmed and smear-positive TB overall, and by World Health Organization (WHO) region. We also investigated time trends in the urban-to-rural prevalence ratio, and associations between urban-to-rural prevalence ratios and survey-level risk of bias (not low versus low), TB screening algorithm (whether used symptom screening for sputum eligibility), national TB incidence, percentage of population living in urban areas, and representativeness of prevalence surveys (national versus sub-national). To estimate the number of people with prevalent TB in urban and rural areas in study countries, and how these have changed between 2000 and 2024, we fitted a Bayesian multivariate model to WHO incidence and case detection ratio data and combined these estimates with assumptions about the duration of treated and untreated TB and the distribution of urban and rural populations. We included 47 surveys conducted between 2000 and 2024, encompassing 2,454,443 participants. The pooled urban-to-rural PR of bacteriologically-confirmed TB was 1.09 (95% credible interval [CrI]: 0.90, 1.30) and was 1.24 (95% CrI: 0.94, 1.61) for smear-positive TB. However, there were substantial differences between WHO regions: averaged across the 24 year study period the African Region had higher urban bacteriologically-confirmed prevalence (PR 1.18, 95% CrI: 0.91, 1.52), while the Western Pacific Region (PR 0.85, 95% CrI: 0.64, 1.07) and South-East Asia Region (PR 0.86, 95% CrI: 0.67, 1.08) had broadly similar urban and rural prevalence. Time trends indicated an increase in the overall bacteriologically-confirmed urban-to-rural prevalence ratio between 2000 and 2024, with a mean PR increase of 2.4% (95% CrI: -0.8%, 6.0%) per year. We estimated that, for 2024 in the 26 represented study countries (combined population: 2.24 billion [48.3%] urban; 2.40 billion [51.7%] rural), 49% (6.6 million, 95% CrI: 4.2, 12.0 million) of prevalent TB was in urban areas, and 51% (6.8 million, 95% CrI: 4.2, 12.0 million) in rural areas. Within countries, there were striking changes in the urban and rural distribution between 2000 and 2024, with the share of urban cases increasing in nearly all countries. The main limitations include lack of unified definitions for urban and rural areas, and absence of data for some global regions (e.g., Americas and Europe). CONCLUSION: Between 2000 and 2024, TB epidemics have become increasingly urbanised, both in proportional and absolute terms, although with considerable variation in timing across countries and regions. Public health approaches tailored to urban and rural TB epidemiology and demography will be required to end TB.
引用
- Mortazavi SA, Swartwood NA, Singh N, et al. Urban and rural prevalence of tuberculosis in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2026. PMID: 41941512. doi:10.1371/journal.pmed.1004779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。